DOXIMITY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.5 USD | +4.29% |
|
-1.68% | -1.93% |
| Jul. 01 | Doximity, Inc.(NYSE:DOCS) added to Russell 1000 Defensive Index | CI |
| Jul. 01 | Doximity, Inc.(NYSE:DOCS) added to Russell 1000 Value-Defensive Index | CI |
Valuation
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 9,966 | 6,268 | 5,020 | 4,890 | - | - |
| Enterprise Value (EV) 1 | 9,167 | 5,427 | 4,257 | 4,067 | 3,943 | 3,991 |
| P/E ratio | 74.4 x | 61.1 x | 37.4 x | 35.3 x | 31.5 x | 25.5 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 29 x | 15 x | 10.6 x | 9.55 x | 8.75 x | 7.9 x |
| EV / Revenue | 26.7 x | 13 x | 8.95 x | 7.94 x | 7.06 x | 6.45 x |
| EV / EBITDA | 61 x | 29.5 x | 18.5 x | 16.6 x | 14.8 x | 13.4 x |
| EV / FCF | 75.8 x | 31.3 x | 23.9 x | 19.8 x | 18.1 x | 17.1 x |
| FCF Yield | 1.32% | 3.2% | 4.19% | 5.05% | 5.53% | 5.86% |
| Price to Book | 11.4 x | 6.5 x | 6.14 x | 5.36 x | 4.45 x | 3.78 x |
| Nbr of stocks (in thousands) | 191,314 | 193,590 | 186,554 | 185,426 | - | - |
| Reference price 2 | 52.09 | 32.38 | 26.91 | 26.37 | 26.37 | 26.37 |
| Announcement Date | 5/17/22 | 5/16/23 | 5/16/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 343.5 | 419.1 | 475.4 | 512.3 | 558.6 | 618.7 |
| EBITDA 1 | - | 150.3 | 184 | 230.5 | 245 | 267.3 | 297.3 |
| EBIT 1 | - | 146.3 | 178.4 | 224.7 | 236.9 | 259 | 291 |
| Operating Margin | - | 42.58% | 42.58% | 47.27% | 46.25% | 46.36% | 47.04% |
| Earnings before Tax (EBT) 1 | - | 114 | 133.2 | 185.2 | 188 | 201.8 | 233.6 |
| Net income 1 | 21.56 | 133.3 | 112.8 | 147.6 | 143.3 | 155.3 | 193.2 |
| Net margin | - | 38.79% | 26.92% | 31.04% | 27.97% | 27.79% | 31.23% |
| EPS 2 | 0.4500 | 0.7000 | 0.5300 | 0.7200 | 0.7473 | 0.8383 | 1.035 |
| Free Cash Flow 1 | - | 120.9 | 173.4 | 178.3 | 205.3 | 218.1 | 233.9 |
| FCF margin | - | 35.19% | 41.38% | 37.5% | 40.07% | 39.04% | 37.81% |
| FCF Conversion (EBITDA) | - | 80.44% | 94.26% | 77.36% | 83.78% | 81.57% | 78.69% |
| FCF Conversion (Net income) | - | 90.71% | 153.71% | 120.81% | 143.29% | 140.45% | 121.08% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 5/28/21 | 5/17/22 | 5/16/23 | 5/16/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 97.88 | 93.65 | 90.64 | 102.2 | 115.3 | 111 | 108.5 | 113.6 | 135.3 | 118.1 | 119.9 | 123.7 | 142.9 | 126 | 132.9 |
| EBITDA 1 | 46.98 | 39.35 | 33.53 | 46 | 55.5 | 48.94 | 46.56 | 54.18 | 73.28 | 56.44 | 55.38 | 58.43 | 72.96 | 58.4 | 61.83 |
| EBIT 1 | 45.89 | 38.24 | 32.36 | 44.61 | 54.08 | 47.35 | 45.15 | 51.58 | 71.84 | 54.95 | 53.6 | 56.32 | 71.06 | 56.33 | 58.9 |
| Operating Margin | 46.88% | 40.83% | 35.71% | 43.66% | 46.92% | 42.67% | 41.63% | 45.4% | 53.1% | 46.55% | 44.71% | 45.53% | 49.74% | 44.72% | 44.31% |
| Earnings before Tax (EBT) 1 | 35.81 | 27.9 | 22.49 | 33.01 | 40.94 | 36.72 | 34.52 | 39.7 | 63.03 | 47.95 | 42.82 | 45.28 | 57.33 | 42.56 | 48.13 |
| Net income 1 | 55.65 | 36.73 | 22.38 | 26.3 | 33.47 | 30.67 | 28.41 | 30.6 | 47.96 | 40.62 | 32.37 | 34.14 | 43.57 | 32.36 | 36.52 |
| Net margin | 56.85% | 39.21% | 24.69% | 25.74% | 29.04% | 27.64% | 26.19% | 26.94% | 35.45% | 34.41% | 27% | 27.6% | 30.5% | 25.69% | 27.47% |
| EPS 2 | 0.2600 | 0.1700 | 0.1000 | 0.1200 | 0.1600 | 0.1400 | 0.1300 | 0.1500 | 0.2400 | 0.2000 | 0.1676 | 0.1778 | 0.2226 | 0.1732 | 0.1900 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/8/22 | 5/17/22 | 8/4/22 | 11/10/22 | 2/9/23 | 5/16/23 | 8/8/23 | 11/9/23 | 2/8/24 | 5/16/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 798 | 841 | 763 | 823 | 946 | 899 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 121 | 173 | 178 | 205 | 218 | 234 |
| ROE (net income / shareholders' equity) | - | 28.2% | 16.8% | 21% | 21.5% | 21% | 19.2% |
| ROA (Net income/ Total Assets) | - | 21.4% | 14.6% | 17.7% | 17.9% | 18% | 16.3% |
| Assets 1 | - | 621.5 | 774.9 | 835.9 | 798.5 | 860.7 | 1,183 |
| Book Value Per Share 2 | - | 4.570 | 4.980 | 4.380 | 4.920 | 5.920 | 6.970 |
| Cash Flow per Share 2 | - | 0.6600 | 0.8400 | 0.8900 | 1.050 | 1.250 | - |
| Capex 1 | - | 1.91 | 1.7 | 0.15 | 1.29 | 1.58 | - |
| Capex / Sales | - | 0.56% | 0.41% | 0.03% | 0.25% | 0.28% | - |
| Announcement Date | 5/28/21 | 5/17/22 | 5/16/23 | 5/16/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
26.37
USD
Average target price
30.15
USD
Spread / Average Target
+14.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.93% | 4.89B | |
| +29.36% | 451B | |
| +41.85% | 294B | |
| +15.41% | 149B | |
| +12.02% | 96.96B | |
| +21.68% | 87.82B | |
| +68.62% | 62.66B | |
| +12.21% | 44.01B | |
| +12.21% | 33.77B | |
| -16.29% | 30.16B |
- Stock Market
- Equities
- DOCS Stock
- Financials Doximity, Inc.
